Exploring the Latest Therapeutic Tools and In Vitro Technologies
Preclinical studies are an integral part of drug development in terms of screening drug candidates for therapeutic efficacy and potential toxic events. 3D culture and organ-on-chip technology are a few examples of the innovations in in vitro/in vivo modelling to...
3 years agoExploring the Latest Therapeutic Tools and In Vitro Technologies
Preclinical studies are an integral part of drug development in terms of screening drug candidates for therapeutic efficacy and potential toxic events. 3D culture and organ-on-chip technology are a few examples of the innovations in in vitro/in vivo modelling to...
3 years agoEmerging Therapeutics in Translational Medicine: Nanotechnology
Hear from some of the industry leaders including David Cook, Chief Scientific Officer, Blueberry Therapeutics who will be providing his expertise in leading a discussion on using translational research techniques to improve drug development. For daily articles on the latest pharma...
3 years agoEmerging Therapeutics in Translational Medicine: Nanotechnology
Hear from some of the industry leaders including David Cook, Chief Scientific Officer, Blueberry Therapeutics who will be providing his expertise in leading a discussion on using translational research techniques to improve drug development. For daily articles on the latest pharma...
3 years agoHow Effective is the Automation and Validating of Human Dose Predictive Models?
Dose prediction is a critical part of drug discovery which determines the safety and efficacy of drugs within patients. Dose response predictions are made with preclinical models which quantify pharmacokinetic (PK) behaviour via a number of parameters. Despite the continuous...
3 years agoHow Effective is the Automation and Validating of Human Dose Predictive Models?
Dose prediction is a critical part of drug discovery which determines the safety and efficacy of drugs within patients. Dose response predictions are made with preclinical models which quantify pharmacokinetic (PK) behaviour via a number of parameters. Despite the continuous...
3 years agoAn Evaluation of -Omics Technology
Omics technologies have proven to be useful molecular tools across many therapeutic areas in facilitating qualitative and quantitative tissue analysis. Spatially Resolved Transcriptomics (SRT) is an example of -omics technology used in oncology to further investigate how the heterogeneity of...
4 years agoAn Evaluation of -Omics Technology
Omics technologies have proven to be useful molecular tools across many therapeutic areas in facilitating qualitative and quantitative tissue analysis. Spatially Resolved Transcriptomics (SRT) is an example of -omics technology used in oncology to further investigate how the heterogeneity of...
4 years agoA Review of CGT: Viral and Non-Viral Approaches
Cell and gene therapies have remained at the forefront of biomedical research for the last decade. While the mechanisms of these therapies differ, both approaches have shown potential across a range of conditions to alleviate symptoms or potentially cure the...
4 years agoA Review of CGT: Viral and Non-Viral Approaches
Cell and gene therapies have remained at the forefront of biomedical research for the last decade. While the mechanisms of these therapies differ, both approaches have shown potential across a range of conditions to alleviate symptoms or potentially cure the...
4 years agoThe Impact of Modern Technology on Clinical Operations
The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...
4 years agoThe Impact of Modern Technology on Clinical Operations
The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...
4 years agoFuture Trends for Pharma and Life Sciences 2021
Given the considerable seismic shifts occurring in the pharmaceutical and life sciences sectors recently, it is no surprise that the major trends and investments of 2021 have seen a similar change in focus. Alzheimer’s Disease, genome editing and cellular therapy...
4 years agoFuture Trends for Pharma and Life Sciences 2021
Given the considerable seismic shifts occurring in the pharmaceutical and life sciences sectors recently, it is no surprise that the major trends and investments of 2021 have seen a similar change in focus. Alzheimer’s Disease, genome editing and cellular therapy...
4 years agoTargeting RNA: A Key Part of Disease Research and Therapeutic Developments
Ribonucleic acid (RNA) has proven in the last decade to be a valid therapeutic target for a multitude of diseases. The ability to manipulate the genetic code to produce almost any protein is one of the many advantages that has...
4 years agoTargeting RNA: A Key Part of Disease Research and Therapeutic Developments
Ribonucleic acid (RNA) has proven in the last decade to be a valid therapeutic target for a multitude of diseases. The ability to manipulate the genetic code to produce almost any protein is one of the many advantages that has...
4 years agoBlockchain, Data mining, and Disruptive Technologies: Digital Innovations in Clinical Research
In the last decade, innovations in data technology have greatly contributed to the quality and transparency of clinical research. System security, clinical trial design, and data analysis are some of the areas which have seen significant modernisation to keep up...
4 years agoBlockchain, Data mining, and Disruptive Technologies: Digital Innovations in Clinical Research
In the last decade, innovations in data technology have greatly contributed to the quality and transparency of clinical research. System security, clinical trial design, and data analysis are some of the areas which have seen significant modernisation to keep up...
4 years agoImplementation of Machine Learning in Drug Development
Significant recent investment in computational technology has seen a number of new innovations arise in drug discovery - perhaps most notable machine learning (ML). By 2022, it is expected that AI technology will contribute $2.199 billion to pharma’s revenue, with...
4 years agoImplementation of Machine Learning in Drug Development
Significant recent investment in computational technology has seen a number of new innovations arise in drug discovery - perhaps most notable machine learning (ML). By 2022, it is expected that AI technology will contribute $2.199 billion to pharma’s revenue, with...
4 years ago